Insider Transactions in Q1 2025 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2025
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
9,689
-4.15%
|
$862,321
$89.86 P/Share
|
|
Jan 03
2025
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
7,152
-20.09%
|
$636,528
$89.86 P/Share
|
|
Jan 03
2025
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
2,342
-6.63%
|
$208,438
$89.86 P/Share
|
|
Jan 02
2025
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
4,119
-10.44%
|
$370,710
$90.02 P/Share
|
|
Jan 01
2025
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,212
-2.18%
|
$463,868
$89.32 P/Share
|
|
Jan 01
2025
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,901
+5.87%
|
-
|
|
Jan 01
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,991
-4.87%
|
$177,199
$89.32 P/Share
|
|
Jan 01
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,456
+13.64%
|
-
|
|
Jan 01
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
4,416
-44.53%
|
$393,024
$89.32 P/Share
|
|
Jan 01
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
8,940
+47.41%
|
-
|
|
Jan 01
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
6,425
-3.97%
|
$571,825
$89.32 P/Share
|
|
Jan 01
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
13,907
+7.9%
|
-
|
|
Jan 01
2025
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
3,278
-8.43%
|
$291,742
$89.32 P/Share
|
|
Jan 01
2025
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
10,430
+21.15%
|
-
|
|
Jan 01
2025
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,656
-1.63%
|
$2,283,384
$89.32 P/Share
|
|
Jan 01
2025
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
57,121
+3.49%
|
-
|
|
Jan 01
2025
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,127
-5.12%
|
$189,303
$89.32 P/Share
|
|
Jan 01
2025
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
4,469
+9.71%
|
-
|